Response of concomitant chronic myelogenous leukemia and chronic lymphocytic leukemia to imatinib mesylate

Saved in:
Bibliographic Details
Published inLeukemia research Vol. 35; no. 9; pp. e179 - e180
Main Authors Yoon, Ju-Yoon, Kumar, Rajat, Aloyz, Raquel, Johnston, James B
Format Journal Article
LanguageEnglish
Published England Elsevier Ltd 01.09.2011
Subjects
Antineoplastic Agents - therapeutic use
Benzamides
Hematology, Oncology and Palliative Medicine
Humans
Imatinib Mesylate
Leukemia, Lymphocytic, Chronic, B-Cell - complications
Leukemia, Lymphocytic, Chronic, B-Cell - drug therapy
Leukemia, Myelogenous, Chronic, BCR-ABL Positive - complications
Leukemia, Myelogenous, Chronic, BCR-ABL Positive - drug therapy
Piperazines - therapeutic use
Pyrimidines - therapeutic use
Treatment Outcome
Online AccessGet full text

Cover

More Information
Bibliography:SourceType-Other Sources-1
content type line 63
ObjectType-Correspondence-1
ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ISSN:0145-2126
1873-5835
DOI:10.1016/j.leukres.2011.06.007